Pain and Meibomian gland dysfunction - from FDA reports


Meibomian gland dysfunction is reported only by a few people with Pain. We study 2 people who have Meibomian gland dysfunction and Pain from FDA . Find out below who they are, other conditions they have and drugs they take.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 21, 2018

2 people who have Pain and Meibomian Gland Dysfunction are studied.


Number of reports submitted per year:

Would you have Meibomian gland dysfunction when you have Pain?

Gender of people who have Pain and experience Meibomian Gland Dysfunction *:

  • female: 50 %
  • male: 50 %

Age of people who have Pain and experience Meibomian Gland Dysfunction *:

Top co-existing conditions for these people *:

  1. Upper Respiratory Tract Infection: 1 person, 50.00%
  2. Stress And Anxiety: 1 person, 50.00%
  3. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 50.00%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 50.00%
  5. Psoriasis (immune-mediated disease that affects the skin): 1 person, 50.00%

Click here to view more results

Most common drugs for these people *:

  1. Oxycodone: 2 people, 100.00%
  2. Zyrtec: 1 person, 50.00%
  3. Flagyl: 1 person, 50.00%
  4. Medrol: 1 person, 50.00%
  5. Lotrel: 1 person, 50.00%

Click here to view more results

Top symptoms for these people *:

  1. Vitiligo (pigment is lost from areas of the skin): 1 person, 50.00%
  2. Hypoaesthesia (reduced sense of touch or sensation): 1 person, 50.00%
  3. Dyspnea Exertional: 1 person, 50.00%
  4. Eye Pain: 1 person, 50.00%
  5. Eyelid Ptosis (falling of the upper or lower eyelid): 1 person, 50.00%

Click here to view more results

* Approximation only. Some reports may have incomplete information.



Do you have Meibomian gland dysfunction with Pain?

You are not alone:




Related studies


Pain

Pain can be treated by Tramadol, Vicodin, Percocet, Tramadol hydrochloride, Hydrocodone bitartrate and acetaminophen (latest reports from 598,543 Pain patients)

Meibomian Gland Dysfunction

Meibomian gland dysfunction (dry eyes) has been reported by people with osteoporosis, glaucoma, diabetic retinal oedema, high blood pressure, dry eyes (latest reports from 158 Meibomian gland dysfunction patients).


Drugs that are associated with Meibomian gland dysfunction
Meibomian gland dysfunction (133 drugs)
Other conditions that could cause Meibomian gland dysfunction
Meibomian gland dysfunction (64 conditions)
Browse all symptoms of Pain
a b c d e f g h i j k l m n o p q r s t u v w x y z

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.